Shattuck Labs, Inc. (STTK)

NASDAQ: STTK · IEX Real-Time Price · USD
2.70
-0.06 (-2.17%)
At close: Sep 30, 2022 4:00 PM
2.57
-0.13 (-4.81%)
After-hours: Sep 30, 2022 5:04 PM EDT
-2.17%
Market Cap 114.43M
Revenue (ttm) 32.03M
Net Income (ttm) -61.46M
Shares Out 42.38M
EPS (ttm) -1.37
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 342,602
Open 2.75
Previous Close 2.76
Day's Range 2.63 - 2.87
52-Week Range 2.55 - 20.95
Beta n/a
Analysts Buy
Price Target 19.18 (+610.4%)
Earnings Date Nov 7, 2022

About STTK

Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is in Phase 1 clinical trial in patients with advanced solid tumors and lymphoma. The company was incorporated in 2016 and is headquartered in Austin, Texas. [Read more...]

Industry Biotechnology
IPO Date Oct 9, 2020
Employees 85
Stock Exchange NASDAQ
Ticker Symbol STTK
Full Company Profile

Financial Performance

In 2021, Shattuck Labs's revenue was $30.02 million, an increase of 202.16% compared to the previous year's $9.93 million. Losses were -$44.97 million, 22.9% more than in 2020.

Financial Statements

Analyst Forecast

According to 11 analysts, the average rating for STTK stock is "Buy." The 12-month stock price forecast is 19.18, which is an increase of 610.37% from the latest price.

Price Target
$19.18
(610.37% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Shattuck Labs Announces Participation in Upcoming September Conferences

AUSTIN, TX & DURHAM, NC, Sept. 01, 2022 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion prote...

1 month ago - GlobeNewsWire

Shattuck Labs Reports Second Quarter 2022 Financial Results and Recent Business Highlights

– Enrollment of Phase 1B clinical trial of SL-172154 in combination with liposomal doxorubicin in platinum-resistant ovarian cancer expected to begin in Q3'2022 with initial combination data expected in...

1 month ago - GlobeNewsWire

Should You Buy Shattuck Labs (STTK) Ahead of Earnings?

Shattuck Labs (STTK) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

4 months ago - Zacks Investment Research

Shattuck Labs Reports First Quarter 2022 Financial Results and Recent Business Highlights

– Dose escalation ongoing in Phase 1 clinical trial of SL-172154 in platinum-resistant ovarian cancer; combination trial with liposomal doxorubicin on track to begin in 2H'2022; full dose-escalation dat...

4 months ago - GlobeNewsWire

Why Earnings Season Could Be Great for Shattuck Labs (STTK)

Shattuck Labs (STTK) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

4 months ago - Zacks Investment Research

Shattuck Labs Presents Preclinical Data at the 2022 American Association for Cancer Research (AACR) Annual Meeting

- SL-9258 (TIGIT-Fc-LIGHT) combined with anti-PD(L)1 broadened anti-tumor activity of the checkpoint antibodies in aggressive CPI-resistant tumors -

5 months ago - GlobeNewsWire

Shattuck Labs Announces Participation in Upcoming 21st Annual Needham Virtual Healthcare Conference

AUSTIN, TX and DURHAM, NC, April 05, 2022 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a ...

5 months ago - GlobeNewsWire

SHATTUCK ALERT: Bragar Eagel & Squire, P.C. is Investigating Shattuck Labs, Inc. on Behalf of Long-Term Stockholders ...

NEW YORK--(BUSINESS WIRE)-- #Class--Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Shattuck Labs, Inc. (NASDAQ: STTK) on beha...

5 months ago - Business Wire

STTK Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Shattuck Labs, Inc. Investors of Last Few Hours to Actively Pa...

NEW YORK--(BUSINESS WIRE)--Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Shattuck Labs, Inc. ("Shattuck" or the "Company"...

6 months ago - Business Wire

STTK SHAREHOLDER ALERT: Jakubowitz Law Reminds Shattuck Shareholders Of A Lead Plaintiff Deadline Of April 1, 2022

NEW YORK, April 1, 2022 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Shattuck Labs, Inc. (NASDAQ: STTK). To receive up...

6 months ago - PRNewsWire

STTK Deadline Tomorrow: ROSEN, Leading Investor Counsel, Encourages Shattuck Labs, Inc. Investors to Secure Counsel B...

New York, New York--(Newsfile Corp. - March 31, 2022) - WHY: New York, N.Y., March 31, 2022. Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Shattuck Labs, Inc...

6 months ago - Newsfile Corp

Deadline Tomorrow Reminder: The Schall Law Firm Encourages Investors in Shattuck Labs, Inc. with Losses of $100,000 t...

Los Angeles, California--(Newsfile Corp. - March 31, 2022) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Shattuck Labs, Inc...

6 months ago - Newsfile Corp

The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Shattuck L...

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz reminds investors of the upcoming April 1, 2022 deadline to file a lead plaintiff motion in the class action filed on behalf of investors w...

6 months ago - Business Wire

STTK LAWSUIT ALERT: Levi & Korsinsky Notifies Shattuck Labs, Inc. Investors of a Class Action Lawsuit and Upcoming De...

NEW YORK , March 31, 2022 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Shattuck Labs, Inc. ("Shattuck" or the "Company") (NASDAQ: STTK) of a class action securities lawsuit. CLASS DEFINIT...

6 months ago - PRNewsWire

Deadline Friday Notice: The Schall Law Firm Encourages Investors in Shattuck Labs, Inc. with Losses of $100,000 to Co...

Los Angeles, California--(Newsfile Corp. - March 30, 2022) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Shattuck Labs, Inc...

6 months ago - Newsfile Corp

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders Of Shattuck Labs, Inc. Of A Class Action Lawsuit And A Le...

NEW YORK, March 30, 2022 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Shattuck Labs, Inc.. Shareholders who purchased shares of STTK during the class period listed a...

Other symbols: NDAQ
6 months ago - PRNewsWire

STTK FINAL DEADLINE FRIDAY: ROSEN, NATIONAL TRIAL COUNSEL, Encourages Shattuck Labs, Inc. Investors With Losses In Ex...

NEW YORK, March 29, 2022 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Shattuck Labs, Inc. (NASDAQ: STTK): (i) pursuant and/or traceable...

6 months ago - PRNewsWire

Deadline Friday Alert: The Schall Law Firm Encourages Investors in Shattuck Labs, Inc. with Losses of $100,000 to Con...

Los Angeles, California--(Newsfile Corp. - March 29, 2022) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Shattuck Labs, Inc...

6 months ago - Newsfile Corp

STTK ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of April 1, 2022 in the Class Action Filed on Beha...

NEW YORK , March 29, 2022 /PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Shattuck Labs, Inc. (NASDAQ: STTK) alleging that the Comp...

6 months ago - PRNewsWire

STTK FRIDAY DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Shattuck Labs, Inc. Investors to Secure Counsel Bef...

New York, New York--(Newsfile Corp. - March 28, 2022) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Shattuck Labs, Inc. (NASDAQ: STTK): (i) pursuant a...

6 months ago - Newsfile Corp

Friday Deadline Reminder: The Schall Law Firm Encourages Investors in Shattuck Labs, Inc. with Losses of $100,000 to ...

Los Angeles, California--(Newsfile Corp. - March 28, 2022) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Shattuck Labs, Inc...

6 months ago - Newsfile Corp

CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Shattuck Investors of a Lead Plaintiff Deadline of April 1...

NEW YORK , March 28, 2022 /PRNewswire/ -- Attention Shattuck Labs, Inc. ("Shattuck") (NASDAQ: STTK) shareholders: The Law Offices of Vincent Wong announce that a class action lawsuit has commenced on be...

6 months ago - PRNewsWire

STTK FINAL DEADLINE NOTICE: ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Shattuck Labs, Inc. Investors with Losses ...

New York, New York--(Newsfile Corp. - March 27, 2022) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Shattuck Labs, Inc. (NASDAQ: STTK): (i) pursuant a...

6 months ago - Newsfile Corp

STTK FINAL DEADLINE FRIDAY: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Shattuck Labs, Inc. Investors with Losses ...

New York, New York--(Newsfile Corp. - March 26, 2022) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Shattuck Labs, Inc. (NASDAQ: STTK): (i) pursuant a...

6 months ago - Newsfile Corp

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Shattuck Labs, Inc. of ...

NEW YORK , March 26, 2022 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Shattuck Labs, Inc. ("Shattuck" or the "Company") (NASDAQ: STTK) and certain of its o...

6 months ago - PRNewsWire